268 Soyombo, A
The transition requires careful dose management since the drugs work differently despite similar effects
Kuen-Jer Tsai, National Cheng Kung University, Taiwan Updates Copyright 2021 Li, Lin, Chen, Guo, Huang, Chen, Lin and Chan
*Correspondence: Hardyanto Soebono, [email protected] This article was submitted to Human and Medical Genomics, a section of the journal Frontiers in Genetics Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Molecular modifications are the primary driver of half-life engineering in modern peptide research
A Reddit user in a BPC-157 forum, Ryan Beattie, told Undark that he decided to try the peptide last year in an effort to live a healthier lifestyle while weaning off the powerful painkillers he had been taking for more than a decade